Investor Relations Home

Accuray Incorporated is a radiation oncology company that develops, manufactures and sells precise, innovative treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. The Company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments.

Accuray does not assume a duty to update information on this website, except through the normal quarterly financial press releases and regulatory filings.

ARAY (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.20 (4.12%)
Data as of Dec 12, 2017 4:00 p.m. ET
Refresh quote
Stock chart for: ARAY.O.  Currently trading at $5.05 with a 52 week high of $6.00 and a 52 week low of $3.60.
Data provided by Nasdaq. Minimum 15 minutes delayed.

Press Releases

Accuray Military Veterans Support U.S. Veteran Community
Advanced Radiation Therapy Systems Manufactured, Installed and Serviced by Accuray Veterans Help Improve the Lives of Military Personnel who are Diagnosed with Cancer SUNNYVALE, Calif., Nov. 8, 2017 /PRNewswire/ -- November 11, 2017 marks Vetera... 
Nov 8, 2017
Treatment Planning for the CyberKnife® System Now Up to 40% Faster
- Accuray Precision™ Treatment Planning System and CyberKnife System Software Upgrade Enhances Efficiency and Ease-of-Use - Leading Radiation Oncology Providers at Institut Gustave Roussy, Lynn Cancer Institute, Multicare Hospital, Queen Elizabeth... 
Oct 26, 2017

Upcoming Investor Event

There are currently no events scheduled.
Some documents in the Investor Relations section require that you have Adobe Acrobat Reader® installed in order to view files in PDF format. Download the newest version of Acrobat Reader